Medline Inc. Financials

MDLN

All currency values in $ millions unless otherwise noted

Income Statement	TTM ~1.6:1 split	DEC 2025	DEC 2024	DEC 2023
Revenues
Revenue	$30,680	$28,432	$25,507	$23,231
Cost of Revenue	$22,785	$20,914	$18,531	$17,346
Gross Profit	$7,895	$7,518	$6,976	$5,885
General & Administrative	$5,047	$4,524	$4,108	$3,867
Research & Development	–	$80	$67	$60
Provision for Doubtful Accounts	$20	$54	$63	$8
Other Operating Expenses	-$401	-$78	-$37	-$106
Total Operating Expenses	$6,153	$5,306	$4,830	$4,635
Operating Income	$1,742	$2,212	$2,146	$1,958
Non-Operating
Net Interest Expense	-$539	-$812	-$864	-$976
Other Non-Operating Income (Expense)	-$85	-$152	-$36	-$718
EBT (Earnings Before Tax)	$1,118	$1,248	$1,246	$264
Income Tax Expense	$242	$91	$46	$30
Minority Interest	$310	-$2	–	–
Net Income
Net Income	$582	$1,159	$1,163	$234
Per Share Data
Revenue Per Share	$23.31	$35.10	–	–
EPS (Basic)	–	-$0.01	–	–
EPS (Diluted)	–	-$0.01	–	–
Weighted Avg Shares (Basic)	876.5M	810.0M	–	–
Weighted Avg Shares (Diluted)	1.32B	810.0M	–	–
Shares Outstanding	1.32B	810.0M	–	–

SourceFinancial statements computed from the 10-Q filed 5 Aug 2026, covering the period ending 27 Jun 2026, as reported to the SEC. Data last refreshed 6 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with MDLN

CompareIntrinsic value

SYKStryker Corporation

$339.65+9.37%66

MMM3M Company

$193.99+9.57%46

BDXBecton, Dickinson and Company

$209.19+5.56%52

BSXBoston Scientific Corporation

$45.82+5.33%80

BAXBaxter International Inc.

$26.50+3.96%32

SOLVSolventum Corporation

$89.35+5.42%38

RMDResMed Inc.

$240.51+5.91%91

DXCMDexCom, Inc.

$88.47+6.63%85

Held by ETFs

MDLN is in 79 US ETFs. The largest of them, with MDLN's weight in each:

Spot a number that looks wrong? Check it in MDLN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MDLN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.